About Chrestos
Chrestos is a company based in Essen (Germany) founded in 2006 was acquired by Buenavista Equity Partners Portugal in November 2024. The company has 54 employees as of December 31, 2021. Chrestos offers products and services including CRO Services and Green Initiatives Consulting. Chrestos operates in a competitive market with competitors including InSilicoTrials, Revolution Medicine, CONTINUUM India, Generable and Cognigen, among others.
- Headquarter Essen, Germany
- Employees 54 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Chrestos Concept Gmbh & Co. Kg
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
54
as on Dec 31, 2021
-
Acquired by
Buenavista Equity Partners Portugal
(Nov 22, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Chrestos
Chrestos offers a comprehensive portfolio of products and services, including CRO Services and Green Initiatives Consulting.
Provides research for medical product development and data analysis.
Offers advice on green mobility and education programs.
Funding Insights of Chrestos
Detailed funding history for Chrestos
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Chrestos
Chrestos has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Buenavista Equity Partners Portugal.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in Venture, Private Equity, and Infrastructures across multiple regions.
|
Locked | Locked | Locked |
Investor details for Chrestos
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Chrestos
Investment portfolio details for Chrestos
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Chrestos
Detailed financials for Chrestos
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Chrestos Comparisons
Peer comparison for Chrestos
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Chrestos
Chrestos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InSilicoTrials, Revolution Medicine, CONTINUUM India, Generable and Cognigen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Healthcare simulation services are provided for medical applications worldwide.
|
|
| Locked | Locked | Locked |
Delivers comprehensive pharmacogenomic testing services for personalized medical solutions.
|
|
| Locked | Locked | Locked |
Offers pharmacovigilance, regulatory, evidence evaluation, and technology solutions to pharma firms.
|
|
| Locked | Locked | Locked |
Precision medicine is delivered via statistical machine learning models.
|
|
| Locked | Locked | Locked |
Strategic clinical pharmacology and pharmacometric consulting services are provided.
|
Detailed competitors of Chrestos
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Chrestos
Complete news archive for Chrestos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chrestos
Chrestos was founded in 2006.
Chrestos is headquartered in Essen, Germany. It is registered at Essen, North Rhine-westphalia, Germany.
As of Dec 31, 2021, the latest employee count at Chrestos is 54.
Chrestos was established in 2006 and is headquartered in Essen, Germany. Operations are centered on contract research organization activities within the pharmaceutical sector. Pharmacokinetic and pharmacodynamic studies are conducted to support drug development processes. Services encompass study design, execution, and data analysis for clients in the biotech and pharma industries. Focus is maintained on regulatory-compliant methodologies across European operations.
Chrestos's top competitors include InSilicoTrials, CONTINUUM India and Generable.
Chrestos offers CRO Services and Green Initiatives Consulting.
Chrestos has 1 investor. Key investors include Buenavista Equity Partners Portugal.